Chime Ajiere
Psychiatric/Mental Health · Frankfort, ILNPI 1851889018
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.6% of the total across 410 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $3,032 and has fallen 55.1% since, to $1,360 in 2025. Among psychiatric/mental health clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 410 payments — averaging $27.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- Johnson & Johnson$2K
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Neuronetics, Inc.$1K
- Alkermes, Inc.$700
- plus $4K from 20 others
What the payments were for
- Food & beverage$10,42193%
- Education$2032%
- Other$6256%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 57 | $1,703 |
| Johnson & Johnson | 49 | $1,664 |
| AbbVie | 69 | $1,290 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 47 | $1,164 |
| Neuronetics, Inc. | 14 | $1,111 |
| Alkermes, Inc. | 34 | $700 |
| Neurocrine Biosciences, Inc. | 15 | $555 |
| Teva Pharmaceuticals USA, Inc. | 20 | $510 |
| Corium, LLC | 13 | $421 |
| Lundbeck LLC | 17 | $375 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $374 |
| Tris Pharma Inc | 9 | $283 |
| Idorsia Pharmaceuticals US Inc | 11 | $241 |
| Axsome Therapeutics, Inc. | 7 | $177 |
| Supernus Pharmaceuticals, Inc. | 5 | $158 |
| Indivior Inc. | 6 | $115 |
| Almatica Pharma LLC | 5 | $106 |
| E.r. Squibb & Sons, L.L.C. | 3 | $69 |
| Braeburn Inc. | 2 | $58 |
| Novo Nordisk | 2 | $42 |
| Ironshore Pharmaceuticals Inc. | 2 | $34 |
| Harmony Biosciences LLC | 2 | $27 |
| Halozyme Inc | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$858
- SPRAVATO$494
- REXULTI$366
- INVEGA SUSTENNA$139
- CAPLYTA$125
- AUSTEDO$117
- ABILIFY MAINTENA$111
- Quillivant$109
- Dyanavel XR$109
- Quillichew ER$109
How this compares
$11,249 in reported general payments places this provider in the 95th percentile of 922 psychiatric/mental health providers in Illinois.
Other psychiatric/mental health in Frankfort
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$151K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.